Literature DB >> 29944579

Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.

Sen Liu1, Guang-Xi Zhong2, Wei-Xun Zhou3, Hua-Dan Xue4, Wei-Dong Pan4, Lai Xu1, Jun-Yang Lu1, Bin Wu1, Guo-le Lin1, Hui-Zhong Qiu1, Yi Xiao1.   

Abstract

BACKGROUND: Patients with locally advanced rectal cancer could be managed by a watch-and-wait approach if they achieve clinical complete response after preoperative chemoradiotherapy. Mucosal integrity, endorectal ultrasound, and rectal MRI are used to evaluate clinical complete response; however, the accuracy remains questionable. Clinical practice based on those assessment methods needs more data and discussion.
OBJECTIVE: The aim of this prospective study was to evaluate the accuracy of mucosal integrity, endorectal ultrasound, and rectal MRI to predict clinical complete response after chemoradiotherapy.
DESIGN: Endorectal ultrasound and rectal MRI were undertaken 6 to 7 weeks after preoperative chemoradiation therapy. Patients then received radical surgery based on the principles of total mesorectal excision. Preoperative tumor staging achieved by endorectal ultrasound and rectal MRI was compared with postoperative staging by pathologic examination. Sensitivity, specificity, and accuracy of each evaluation method were calculated. SETTINGS: The study was conducted at a single tertiary care center. PATIENTS: Patients diagnosed with mid-low rectal cancer by biopsy between May 2014 and December 2016 were enrolled in this study.
RESULTS: A total of 124 patients were enrolled in this study, and postoperative pathology revealed that 20 patients (16.13%) achieved complete response (ypT0N0). The sensitivity of mucosal integrity, endorectal ultrasound, and MRI to predict clinical complete response was 25%. The specificity of mucosal integrity, endorectal ultrasound, and MRI was 94.23%, 93.90%, and 93.27%. The combination of each 2 or all 3 methods did not improve accuracy. Regression analysis showed that none of these methods could predict postoperative ypT0. LIMITATIONS: The sample size is small, and we did not focus on the follow-up data and cannot compare prognosis data with previous research studies.
CONCLUSIONS: Both single-method and combined mucosal integrity, endorectal ultrasound, and rectal MRI have poor correlation with postoperative pathologic examination. A watch-and-wait approach based on these methods might not be a proper strategy compared with radical surgery after neoadjuvant therapy. See Video Abstract at http://links.lww.com/DCR/A693.

Entities:  

Mesh:

Year:  2018        PMID: 29944579     DOI: 10.1097/DCR.0000000000001135

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  Rectal Endoscopic Ultrasound in Clinical Practice.

Authors:  Stephen Hasak; Vladimir Kushnir
Journal:  Curr Gastroenterol Rep       Date:  2019-04-12

2.  Endoscopy-Based Deep Convolutional Neural Network Predicts Response to Neoadjuvant Treatment for Locally Advanced Rectal Cancer.

Authors:  Xijie Chen; Junguo Chen; Xiaosheng He; Liang Xu; Wei Liu; Dezheng Lin; Yuxuan Luo; Yue Feng; Lei Lian; Jiancong Hu; Ping Lan
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

3.  Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning.

Authors:  Xiandong Leng; K M Shihab Uddin; William Chapman; Hongbo Luo; Sitai Kou; Eghbal Amidi; Guang Yang; Deyali Chatterjee; Anup Shetty; Steve Hunt; Matthew Mutch; Quing Zhu
Journal:  Radiology       Date:  2021-03-23       Impact factor: 11.105

4.  Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence.

Authors:  Satoshi Murahashi; Takashi Akiyoshi; Takeshi Sano; Yosuke Fukunaga; Tetsuo Noda; Masashi Ueno; Hitoshi Zembutsu
Journal:  Br J Cancer       Date:  2020-06-22       Impact factor: 7.640

5.  MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.

Authors:  Seong Ho Park; Seung Hyun Cho; Sang Hyun Choi; Jong Keon Jang; Min Ju Kim; Seung Ho Kim; Joon Seok Lim; Sung Kyoung Moon; Ji Hoon Park; Nieun Seo
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

6.  High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.

Authors:  Siyi Lu; Zhenzhen Liu; Bingyan Wang; Fei Li; Yan Meng; Junwei Wang; Yuxia Wang; Hao Wang; Xin Zhou; Wei Fu
Journal:  Cancer Cell Int       Date:  2021-04-13       Impact factor: 5.722

7.  Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer.

Authors:  Ja Kyung Lee; Jung Rae Cho; Kwang-Seop Song; Jae Hwan Oh; Seung-Yong Jeong; Min Jung Kim; Jeehye Lee; Min Hyun Kim; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang
Journal:  Ann Surg Treat Res       Date:  2021-07-29       Impact factor: 1.859

8.  Rectal Cancer Treatment Management: Deep-Learning Neural Network Based on Photoacoustic Microscopy Image Outperforms Histogram-Feature-Based Classification.

Authors:  Xiandong Leng; Eghbal Amidi; Sitai Kou; Hassam Cheema; Ebunoluwa Otegbeye; William Jr Chapman; Matthew Mutch; Quing Zhu
Journal:  Front Oncol       Date:  2021-09-23       Impact factor: 5.738

9.  The predictive value of tumor volume reduction ratio on three-dimensional endorectal ultrasound for tumor response to chemoradiotherapy for locally advanced rectal cancer.

Authors:  Limei Chen; Xiaoyin Liu; Wenjing Zhang; Si Qin; Yimin Wang; Jing Lin; Qiu Chen; Guangjian Liu
Journal:  Ann Transl Med       Date:  2022-06

Review 10.  Watch and wait approach in rectal cancer: Current controversies and future directions.

Authors:  Fernando López-Campos; Margarita Martín-Martín; Roberto Fornell-Pérez; Juan Carlos García-Pérez; Javier Die-Trill; Raquel Fuentes-Mateos; Sergio López-Durán; José Domínguez-Rullán; Reyes Ferreiro; Alejandro Riquelme-Oliveira; Asunción Hervás-Morón; Felipe Couñago
Journal:  World J Gastroenterol       Date:  2020-08-07       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.